Related Experiment Video
Updated: May 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Modeling a lethal prostate cancer variant with small-cell carcinoma features
Vassiliki Tzelepi1, Jiexin Zhang, Jing-Fang Lu
1Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
New xenografts model small-cell prostate carcinoma (SCPC), revealing key gene changes like UBE2C upregulation and loss of AR/RB1/CCND1 expression. These models aid understanding of aggressive prostate cancer biology.
Area of Science:
- Oncology
- Cancer Biology
- Genomics
Background:
- Small-cell prostate carcinoma (SCPC) exhibits distinct aggressive behavior and treatment resistance.
- Understanding SCPC biology is crucial for developing effective therapies.
Purpose of the Study:
- To develop and characterize novel xenograft models that accurately reflect human SCPC.
- To investigate the molecular and genomic profiles of SCPC xenografts.
Main Methods:
- Development of castration-resistant prostate carcinoma xenografts.
- Comparison of gene expression and genomic profiles between SCPC/LCNEC and adenocarcinoma xenografts.
- Immunohistochemical validation in 60 human prostate cancer samples.
Main Results:
- SCPC/LCNEC xenografts show high fidelity to human tumors, with UBE2C and mitotic gene upregulation.
- Loss of androgen receptor (AR), retinoblastoma (RB1), and cyclin D1 (CCND1) expression observed.
- Increased copy number variations in SCPC/LCNEC xenografts, including UBE2C amplification and RB1 microdeletions.
Conclusions:
- Xenograft models provide valuable tools for studying prostate carcinoma biology.
- Findings highlight the importance of UBE2C, AR, RB1, and CCND1 in SCPC pathogenesis.
- Future studies will explore the functional implications of these molecular alterations.

